As long as UNODC continues to carefully and deliberately hold back from mentioning the harmful impact of states’ own drug policies, we cannot trust the agency to communicate all the facts.

In one of her first tweets after assuming the presidency, Ms Pavadia stressed that drug control measures must respect human rights – a welcome statement that follows the INCB’s new emphasis on human rights, already assumed by her predecessor, Mr Cornelis de Joncheere.

IDPC provides an overview of INCB activities over the past quarter.

IDPC provides a critique of the UNODC Strategy 2021-2025 with a focus on two critical issues: the exclusion of civil society and communities from the development and approval of the document; and the departure from the policy priorities established in the 2018 UN system Common Position on drugs.

IDPC takes stock of progress made on the implementation of the recommendations included in the UNGASS Outcome Document, focusing on six critical areas: public health, development, human rights, civil society engagement, UN agency collaboration and cooperation, and drug policy evaluation.

Stark contrasts are emerging in the global community on how to address the legality of cannabis, as the INCB meets with Filipino and Uruguayan drug control representatives.

Following the release of the UN World Drug Report, IDPC notes with concern that the UNODC is still unable to acknowledge the failure of decades of drug policies based on prohibition and punishment, and how these approaches fuel systemic human rights abuses such as racism, police violence and…

The INCB holds three sessions a year, typically in February, May, and November of each year. The dates and agenda of each session can be consulted here.

The INCB's annual report analyses the state of the global drug control regime and makes recommendations to member states, including on better aligning drug policy and human rights.